Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Pharma has informed that the Analyst or Institutional Investor Meetings will be held on January 9th to 12th, 2023 with JP Morgan Healthcare in San Francisco USA. Dates are subject to changes and changes may happen due to exigencies on the part of Investors / Company.
The above information is a part of company’s filings submitted to BSE.